Koninklijke Philips ROA 2012-2026 | PHG
Current and historical return on assets (ROA) values for Koninklijke Philips (PHG) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Koninklijke Philips ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2026-06-30 | $1.28B | $31.06B | 4.13% |
| 2026-03-31 | $1.11B | $30.78B | 3.60% |
| 2025-12-31 | $1.01B | $29.96B | 3.38% |
| 2025-09-30 | $0.77B | $22.34B | 3.43% |
| 2025-06-30 | $1.04B | $22.58B | 4.59% |
| 2025-03-31 | $0.84B | $23.13B | 3.65% |
| 2024-09-30 | $0.05B | $15.98B | 0.31% |
| 2024-06-30 | $-0.17B | $24.62B | -0.70% |
| 2023-06-30 | $-0.48B | $25.43B | -1.88% |
| 2023-03-31 | $-0.33B | $24.95B | -1.31% |
| 2022-06-30 | $0.66B | $32.35B | 2.04% |
| 2021-06-30 | $0.68B | $31.11B | 2.20% |
| 2020-06-30 | $0.78B | $30.47B | 2.55% |
| 2019-06-30 | $1.23B | $31.84B | 3.86% |
| 2018-06-30 | $1.37B | $33.05B | 4.14% |
| 2017-06-30 | $1.84B | $34.43B | 5.35% |
| 2016-12-31 | $1.60B | $34.54B | 4.64% |
| 2016-09-30 | $0.87B | $34.21B | 2.55% |
| 2016-06-30 | $0.81B | $33.98B | 2.40% |
| 2016-03-31 | $0.64B | $33.75B | 1.90% |
| 2015-12-31 | $0.72B | $34.51B | 2.08% |
| 2015-09-30 | $0.94B | $35.33B | 2.65% |
| 2015-06-30 | $0.44B | $36.20B | 1.23% |
| 2015-03-31 | $0.48B | $36.46B | 1.30% |
| 2014-12-31 | $0.55B | $36.38B | 1.52% |
| 2014-09-30 | $0.94B | $35.78B | 2.62% |
| 2014-06-30 | $1.45B | $35.57B | 4.07% |
| 2014-03-31 | $1.53B | $35.79B | 4.28% |
| 2013-12-31 | $1.55B | $36.37B | 4.27% |
| 2013-09-30 | $0.52B | $36.90B | 1.41% |
| 2013-06-30 | $0.37B | $36.95B | 0.99% |
| 2013-03-31 | $0.16B | $37.32B | 0.42% |
| 2012-12-31 | $0.27B | $37.54B | 0.72% |
| 2012-09-30 | $0.54B | $38.28B | 1.41% |
| 2012-06-30 | $0.42B | $38.99B | 1.08% |
| 2012-03-31 | $-1.72B | $39.37B | -4.36% |
| 2011-12-31 | $-1.85B | $39.90B | -4.63% |
| 2011-09-30 | $-1.00B | $40.53B | -2.48% |
| 2011-06-30 | $-0.43B | $41.19B | -1.04% |
| 2011-03-31 | $1.84B | $42.37B | 4.33% |
| 2010-12-31 | $1.91B | $43.17B | 4.43% |
| 2010-09-30 | $1.67B | $43.10B | 3.87% |
| 2010-06-30 | $1.25B | $43.13B | 2.89% |
| 2010-03-31 | $0.98B | $42.07B | 2.33% |
| 2009-12-31 | $0.63B | $41.41B | 1.51% |
| 2009-09-30 | $-2.02B | $42.92B | -4.71% |
| 2009-06-30 | $-1.74B | $45.27B | -3.84% |
| 2009-03-31 | $-0.68B | $48.66B | -1.39% |
| 2008-12-31 | $-0.27B | $52.48B | -0.52% |
| 2008-09-30 | $3.90B | $52.79B | 7.39% |
| 2008-06-30 | $3.82B | $52.12B | 7.33% |
| 2008-03-31 | $4.81B | $51.16B | 9.40% |
| 2007-12-31 | $5.63B | $49.18B | 11.44% |
| 2007-09-30 | $4.44B | $48.81B | 9.10% |
| 2007-06-30 | $9.40B | $49.20B | 19.10% |
| 2007-03-31 | $7.66B | $48.26B | 15.88% |
| 2006-12-31 | $6.71B | $47.55B | 14.11% |
| 2006-09-30 | $6.38B | $46.00B | 13.87% |
| 2006-06-30 | $2.94B | $43.32B | 6.78% |
| 2006-03-31 | $4.37B | $41.82B | 10.45% |
| 2005-12-31 | $4.33B | $40.14B | 10.80% |
| 2005-09-30 | $4.87B | $39.99B | 12.17% |
| 2005-06-30 | $4.33B | $39.68B | 10.90% |
| 2005-03-31 | $3.26B | $39.26B | 8.30% |
| 2004-12-31 | $3.79B | $39.12B | 9.69% |
| 2004-09-30 | $3.58B | $37.86B | 9.44% |
| 2004-06-30 | $2.28B | $36.85B | 6.19% |
| 2004-03-31 | $1.59B | $36.12B | 4.39% |
| 2003-12-31 | $0.83B | $34.90B | 2.37% |
| 2003-09-30 | $-1.42B | $34.23B | -4.14% |
| 2003-06-30 | $-1.88B | $34.35B | -5.48% |
| 2003-03-31 | $-3.18B | $34.37B | -9.25% |
| 2002-12-31 | $-3.09B | $34.33B | -9.01% |
| 2002-09-30 | $-2.58B | $34.38B | -7.51% |
| 2002-06-30 | $-2.97B | $34.10B | -8.70% |
| 2002-03-31 | $-2.38B | $33.86B | -7.03% |
| 2001-12-31 | $-2.30B | $34.55B | -6.65% |
| 2001-09-30 | $1.20B | $35.03B | 3.41% |
| 2001-06-30 | $3.78B | $34.87B | 10.83% |
| 2001-03-31 | $7.81B | $34.34B | 22.75% |
| 2000-12-31 | $8.84B | $32.83B | 26.93% |
| 2000-09-30 | $7.08B | $31.28B | 22.64% |
| 2000-06-30 | $5.60B | $30.33B | 18.47% |
| 2000-03-31 | $2.52B | $29.62B | 8.50% |
| 1999-12-31 | $1.92B | $30.07B | 6.38% |
| 1999-09-30 | $6.71B | $30.45B | 22.05% |
| 1999-06-30 | $6.54B | $23.16B | 28.21% |
| 1999-03-31 | $6.76B | $15.90B | 42.50% |
| 1998-12-31 | $6.58B | $7.83B | 83.93% |
| 1998-09-30 | $2.42B | $7.59B | 31.83% |
| 1998-06-30 | $2.91B | $7.59B | 38.29% |
| 1998-03-31 | $2.78B | $7.59B | 36.69% |
| 1997-12-31 | $2.92B | $7.59B | 38.45% |
| 1997-09-30 | $1.02B | $8.14B | 12.53% |
| 1997-06-30 | $0.39B | $8.14B | 4.75% |
| 1997-03-31 | $-0.27B | $8.14B | -3.29% |
| 1996-12-31 | $-0.32B | $8.14B | -3.98% |
| 1996-09-30 | $0.64B | $8.11B | 7.83% |
| 1996-06-30 | $0.90B | $8.11B | 11.07% |
| 1996-03-31 | $1.54B | $8.11B | 18.97% |
| 1995-12-31 | $1.57B | $8.11B | 19.30% |
| 1995-09-30 | $1.70B | $3.59B | 47.44% |
| 1995-06-30 | $1.66B | $3.59B | 46.38% |
| 1995-03-31 | $1.51B | $3.59B | 42.03% |
| 1994-12-31 | $1.19B | $3.59B | 33.30% |
| 1994-09-30 | $0.92B | $6.21B | 14.87% |
| 1994-06-30 | $0.70B | $6.21B | 11.21% |
| 1994-03-31 | $-0.10B | $6.21B | -1.58% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $24.651B | $20.173B |
| Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $178.385B | 19.60 |
| Medtronic (MDT) | Ireland | $119.983B | 16.40 |
| Stryker (SYK) | United States | $108.118B | 20.21 |
| EssilorLuxottica (ESLOY) | France | $79.433B | 0.00 |
| Boston Scientific (BSX) | United States | $65.288B | 14.03 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.930B | 0.00 |
| Medline (MDLN) | United States | $42.846B | 0.00 |
| Agilent Technologies (A) | United States | $41.387B | 24.22 |
| ResMed (RMD) | United States | $32.167B | 19.96 |
| GE HealthCare Technologies (GEHC) | United States | $29.021B | 13.88 |
| Terumo (TRUMY) | Japan | $21.625B | 20.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.414B | 11.38 |
| Baxter (BAX) | United States | $12.336B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.926B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.854B | 39.71 |
| Demant (WILYY) | Denmark | $9.592B | 0.00 |
| Insulet (PODD) | United States | $9.557B | 23.48 |
| Sunny Optical Technology (SNPTF) | China | $9.142B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.548B | 20.15 |
| Raia Drogasil SA - (RADLY) | $4.931B | 0.00 | |
| Haemonetics (HAE) | United States | $4.837B | 21.22 |
| BillionToOne (BLLN) | United States | $4.757B | 144.03 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| Envista Holdings (NVST) | United States | $4.142B | 17.54 |
| ICU Medical (ICUI) | United States | $3.939B | 23.52 |
| AtriCure (ATRC) | United States | $2.838B | 242.57 |
| Neogen (NEOG) | United States | $2.606B | 45.96 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| Curaleaf Holdings (CURLF) | United States | $2.356B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.256B | 10.77 |
| Trulieve Cannabis (TRLV) | United States | $2.238B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.207B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.894B | 5.46 |
| LeMaitre Vascular (LMAT) | United States | $1.847B | 29.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.736B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.733B | 221.44 |
| Phibro Animal Health (PAHC) | United States | $1.459B | 11.20 |
| Green Thumb Industries (GTBIF) | United States | $1.428B | 15.23 |
| Kestra Medical Technologies (KMTS) | United States | $1.410B | 0.00 |
| Omeros (OMER) | United States | $1.264B | 6.40 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.094B | 0.00 |
| CeriBell (CBLL) | United States | $0.934B | 0.00 |
| InMode (INMD) | Israel | $0.856B | 11.91 |
| AdaptHealth (AHCO) | United States | $0.802B | 16.80 |
| VAREX IMAGING (VREX) | United States | $0.777B | 17.09 |
| QuidelOrtho (QDEL) | United States | $0.763B | 8.24 |
| Glass House Brands (GLAS) | United States | $0.760B | 0.00 |
| Valneva SE (VALN) | France | $0.633B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.582B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.564B | 0.00 |
| Brainsway (BWAY) | Israel | $0.548B | 30.98 |
| Evolus (EOLS) | United States | $0.524B | 0.00 |
| Cerus (CERS) | United States | $0.514B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.512B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.438B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.373B | 0.00 |
| SNDL (SNDL) | Canada | $0.353B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.337B | 24.56 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.294B | 0.00 |
| MacroGenics (MGNX) | United States | $0.268B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 13.14 |
| High Tide (HITI) | Canada | $0.234B | 52.60 |
| OraSure Technologies (OSUR) | United States | $0.232B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.225B | 21.55 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.178B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.152B | 0.00 |
| Apyx Medical (APYX) | United States | $0.127B | 0.00 |
| Quanterix (QTRX) | United States | $0.118B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.088B | 121.38 |
| Accendra Health (ACH) | United States | $0.086B | 4.87 |
| FitLife Brands (FTLF) | United States | $0.086B | 11.30 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.052B | 0.00 |
| Biote (BTMD) | United States | $0.050B | 4.12 |
| Nephros (NEPH) | United States | $0.048B | 40.27 |
| Veru (VERU) | United States | $0.040B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.037B | 17.71 |
| United-Guardian (UG) | United States | $0.033B | 13.26 |
| Rockwell Medical (RMTI) | United States | $0.031B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.022B | 0.00 |
| Modular Medical (MODD) | United States | $0.021B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.019B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |